AI 90-DAY FORECAST

NEUTRAL SIGNAL · Alpha

██.█% Sign up free to reveal

Alterity Therapeutics Ltd (ATHE) AI Forecast

Our AI analyzed Alterity Therapeutics Ltd. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$ATHE Neutral Signal Full forecast available

Alterity Therapeutics Ltd (ATHE) Stock Forecast Sept. 24, 2026

Q: What factors influence Alterity Therapeutics Ltd stock price forecasts?

Our analysis considers financial metrics, sector trends, market sentiment, technical indicators, and macroeconomic factors.

Alterity Therapeutics Ltd (ATHE) AI Stock Price Forecast & Investment Analysis

Latest Analysis Date: September 24, 2026

Loading chart...

Alterity Therapeutics Ltd (ATHE) - Comprehensive Stock Analysis & Investment Research

Deep dive into Alterity Therapeutics Ltd's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on September 24, 2026 (UTC)

Alterity Therapeutics Ltd Investment Summary

When evaluating whether Alterity Therapeutics Ltd (ATHE) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Alterity Therapeutics Ltd (ATHE) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $32 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Alterity Therapeutics Ltd's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Alterity Therapeutics Ltd along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Alterity Therapeutics Ltd is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Alterity Therapeutics Ltd

Corporate Identity

Alterity Therapeutics Ltd (Stock Symbol: ATHE) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Alterity Therapeutics Ltd's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Alterity Therapeutics Ltd...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Alterity Therapeutics Ltd...

Unlock Full Company Profile

Get complete details about Alterity Therapeutics Ltd

Revenue & Growth Analysis

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Alterity Therapeutics Ltd...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Alterity Therapeutics Ltd...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Alterity Therapeutics Ltd...

Unlock Financial Analysis

Get complete financial metrics for Alterity Therapeutics Ltd

AI ANALYSIS AVAILABLE

Unlock Alterity Therapeutics Ltd's AI Price Forecast

Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

4537 Stocks in the out-of-sample test

73.7% Rebalance periods with a positive net return

Daily Updates

Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Alterity Therapeutics Ltd strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Alterity Therapeutics Ltd competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

Financial Strength & Leverage

Alterity Therapeutics Ltd (ATHE) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Alterity Therapeutics Ltd stock analysis. Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.

Deep dive into Alterity Therapeutics Ltd's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Alterity Therapeutics Ltd stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.